28 September 2023
Dekel Agri-Vision PLC
('Dekel' or the 'Company')
Issue of Equity
Dekel Agri-Vision Plc (AIM: DKL), the West African agriculture company focused on building a portfolio of sustainable and diversified projects, announces that, pursuant to their contract, an employee of the Company and certain advisers to the Company are to be issued an aggregate of 867,800 ordinary shares in the Company in settlement of fees for services provided.
Application will be made to the London Stock Exchange for the admission of a total of 867,800 ordinary shares of €0.0003367 each ("Ordinary Shares") to trading on AIM ("Admission"). It is expected that Admission will become effective on or around 4 October 2023. Following Admission, the Company's issued share capital will consist of 559,404,153 Ordinary Shares.
** ENDS **
This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.
For further information, please visit the Company's website www.dekelagrivision.com or contact:
Dekel Agri-Vision Plc Youval Rasin Shai Kol Lincoln Moore
| +44 (0) 207 236 1177 |
WH Ireland Ltd (Nomad and Joint Broker) James Joyce Darshan Patel Isaac Hooper
| +44 (0) 20 7220 1666 |
Optiva Securities Limited (Joint Broker) Christian Dennis Daniel Ingram
| +44 (0) 203 137 1903 |
Notes:
Dekel Agri-Vision Plc is a multi-project, multi-commodity agriculture company focused on West Africa. It has a portfolio of projects in Côte d'Ivoire at various stages of development: a fully operational palm oil project in Ayenouan where fruit produced by local smallholders is processed at the Company's 60,000tpa capacity crude palm oil mill and a cashew processing project in Tiebissou, which is currently transitioning to full commercial production in 2023.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.